Clinical Trials Directory

Trials / Completed

CompletedNCT04574479

Supra-inguinal Fascia Iliaca Compartment Block on Postoperative Management in Total Hip Arthroplasty by Posterior Approach

Impact of Supra-inguinal Fascia Iliaca Compartment Block on Postoperative Opioid Consumption in Total Hip Arthroplasty Interventions by Posterior Approach

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
86 (actual)
Sponsor
University of Liege · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

Find the impact of supra-inguinal fascia iliaca compartment block on postoperative pain management after total hip arthroplasty by posterior surgical approach

Detailed description

ASA physical status 1, 2 and 3 patients scheduled to undergo elective surgery of total hip arthroplasty under spinal anesthesia. The investigators would like to study the impact of supra-inguinal fascia iliaca block on postoperative pain management after total hip arthroplasty by posterior surgical approach. The principal investigator perform this block with ultrasound technique. The investigators also want to observe if this loco-regional new approach to fascia iliaca block could have influence on opioid side effects, postoperative nausea and vomiting, length of hospitalisation and first mobilisation side effects.

Conditions

Interventions

TypeNameDescription
PROCEDURESupra-inguinal fascia iliaca compartment blockUltrasound guided loco-regional technique as described by Desmet et al. Fascia iliaca compartment block with in-plane 40 ml ropivacaine 0,375% injection between the ilio-psoas muscle and the internal oblique muscle. Patients in SFICB group have classical multimodal approach to postoperative analgesia with morphine administration by PCA pump
DRUGMultimodal analgesia and PCA morphine pumpPatients in placebo group have classical multimodal approach to postoperative analgesia with morphine administration by PCA pump

Timeline

Start date
2020-12-16
Primary completion
2021-09-01
Completion
2021-09-02
First posted
2020-10-05
Last updated
2022-05-17

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04574479. Inclusion in this directory is not an endorsement.